News >

AML Research Focus Adapting to Address Heterogeneity

Ellie Leick
Published: Friday, Sep 20, 2019

Gary J. Schiller, MD, irector of hematologic malignancies in the Stem Cell Transplant Unit in the David Geffen School of Medicine at University of California, Los Angeles

Gary J. Schiller, MD

Within the past few years, research in acute myeloid leukemia (AML) has shifted to showcase the heterogeneity of the disease. Now, the availability of both targeted and broad-spectrum drugs demonstrates the focus to approach AML management in a number of different ways, explained Gary J. Schiller, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x